You had searched for:
There were no results matching the query.
You can also browse the topics below to find what you are looking for.
Data on dosing periods of AJOVY
The post hoc analyses from the long-term open-label extension study evaluated: the mean number of weekly migraine days during weeks 1-2 vs weeks 11-12, as well as the mean number of weekly migraine days during weeks 1-3 vs week 4 at months 3, 6, 9, and 15 with quarterly and monthly dosing.1
For all post hoc analyses, no determination of statistical significance can be made and no conclusions should be drawn.